Literature DB >> 20629734

Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.

Maider Ibarrola-Villava1, Lara P Fernandez, Guillermo Pita, Jerónimo Bravo, Uxua Floristan, Elena Sendagorta, Marta Feito, José A Avilés, Manuel Martin-Gonzalez, Pablo Lázaro, Javier Benítez, Gloria Ribas.   

Abstract

The CDKN2A gene is regarded as the major familial malignant melanoma (MM) susceptibility gene. Human pigmentation is one of the main modulators of individual risk of developing MM. Therefore, the genes involved in the determination of skin colour and tanning response are potentially implicated in MM predisposition and may be useful predictors of MM risk in the general population. The human melanocortin-1 receptor gene (MC1R) plays a crucial role in pigmentation and also appears to be important in MM. The OCA2 gene has emerged as a new and significant determinant of human iris colour variation. We present a case-control study in Spanish population including 390 consecutive patients with melanoma and 254 control subjects. Sequence analysis of the entire coding region and genotyping of 5 tag-SNPs in the genomic region of MC1R was performed. We identified 27 variants, two reaching statistical significance [R160W (OR: 4.18, 95% CI: 1.24-14.04, P = 0.02) and D294H (OR: 3.10, 95% CI: 1.37-7.01, P = 0.01)] and we detected two novel non-synonymous changes: V92L and T308M. Odds ratio for carrying two functional variants was 4.25 (95% CI: 2.30-7.84, P = 3.63 x 10(-6)). Haplotypes of the entire MC1R region have been established, and we observed an enrichment of a rare European haplotype similar to African values carrying variants V92M and I155T. In addition, three potentially functional SNPs were selected in p16/CDKN2A and in the promoter region of OCA2/HERC2. Our data for CDKN2A gene did not reach statistically significant results for any of the two studied alleles. We found that the variant allele A > G of OCA2/HERC2 (rs12913832) was associated with pigmentation features: eye, hair and skin colour; P-values = 1.8 x 10(-29), 9.2 x 10(-16), 1.1 x 10(-3), respectively, validating previous results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629734     DOI: 10.1111/j.1600-0625.2010.01115.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  13 in total

1.  Modeling MC1R rare variants: a structural evaluation of variants detected in a Mediterranean case-control study.

Authors:  Maider Ibarrola-Villava; Maria Peña-Chilet; Marta J Llorca-Cardeñosa; Sara Oltra; Conrado-Martinez Cadenas; Jeronimo Bravo; Gloria Ribas
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

2.  Pharmacologic induction of epidermal melanin and protection against sunburn in a humanized mouse model.

Authors:  Alexandra Amaro-Ortiz; Jillian C Vanover; Timothy L Scott; John A D'Orazio
Journal:  J Vis Exp       Date:  2013-09-07       Impact factor: 1.355

3.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

Review 4.  Functional and pathological relevance of HERC family proteins: a decade later.

Authors:  Susana Sánchez-Tena; Monica Cubillos-Rojas; Taiane Schneider; Jose Luis Rosa
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

5.  A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene.

Authors:  Maider Ibarrola-Villava; Lara P Fernandez; Santos Alonso; M Dolores Boyano; Maria Peña-Chilet; Guillermo Pita; Jose A Aviles; Matias Mayor; Cristina Gomez-Fernandez; Beatriz Casado; Manuel Martin-Gonzalez; Neskuts Izagirre; Concepcion De la Rua; Aintzane Asumendi; Gorka Perez-Yarza; Yoana Arroyo-Berdugo; Enrique Boldo; Rafael Lozoya; Arantxa Torrijos-Aguilar; Ana Pitarch; Gerard Pitarch; Jose M Sanchez-Motilla; Francisca Valcuende-Cavero; Gloria Tomas-Cabedo; Gemma Perez-Pastor; Jose L Diaz-Perez; Jesus Gardeazabal; Iñigo Martinez de Lizarduy; Ana Sanchez-Diez; Carlos Valdes; Angel Pizarro; Mariano Casado; Gregorio Carretero; Rafael Botella-Estrada; Eduardo Nagore; Pablo Lazaro; Ana Lluch; Javier Benitez; Conrado Martinez-Cadenas; Gloria Ribas
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Cuba: exploring the history of admixture and the genetic basis of pigmentation using autosomal and uniparental markers.

Authors:  Beatriz Marcheco-Teruel; Esteban J Parra; Evelyn Fuentes-Smith; Antonio Salas; Henriette N Buttenschøn; Ditte Demontis; María Torres-Español; Lilia C Marín-Padrón; Enrique J Gómez-Cabezas; Vanesa Alvarez-Iglesias; Ana Mosquera-Miguel; Antonio Martínez-Fuentes; Angel Carracedo; Anders D Børglum; Ole Mors
Journal:  PLoS Genet       Date:  2014-07-24       Impact factor: 5.917

7.  Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.

Authors:  Matthew F Buas; David M Levine; Karen W Makar; Heidi Utsugi; Lynn Onstad; Xiaohong Li; Patricia C Galipeau; Nicholas J Shaheen; Laura J Hardie; Yvonne Romero; Leslie Bernstein; Marilie D Gammon; Alan G Casson; Nigel C Bird; Harvey A Risch; Weimin Ye; Geoffrey Liu; Douglas A Corley; Patricia L Blount; Rebecca C Fitzgerald; David C Whiteman; Anna H Wu; Brian J Reid; Thomas L Vaughan
Journal:  Carcinogenesis       Date:  2014-10-03       Impact factor: 4.944

Review 8.  Circadian Rhythm of NER and ATR Pathways.

Authors:  Tae-Hong Kang
Journal:  Biomolecules       Date:  2021-05-11

9.  Variants at the 9p21 locus and melanoma risk.

Authors:  Livia Maccioni; Panduranga Sivaramakrishna Rachakonda; Justo Lorenzo Bermejo; Dolores Planelles; Celia Requena; Kari Hemminki; Eduardo Nagore; Rajiv Kumar
Journal:  BMC Cancer       Date:  2013-07-02       Impact factor: 4.430

10.  Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.

Authors:  Yoana Arroyo-Berdugo; Santos Alonso; Gloría Ribas; Maider Ibarrola-Villava; María Peña-Chilet; Conrado Martínez-Cadenas; Jesús Gardeazabal; Juan Antonio Ratón-Nieto; Ana Sánchez-Díez; Jesús María Careaga; Gorka Pérez-Yarza; Gregorio Carretero; Manuel Martín-González; Cristina Gómez-Fernández; Eduardo Nagore; Aintzane Asumendi; María Dolores Boyano
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.